Global Active Pharmaceutical Ingredients Market 2017-2021

医薬品有効成分(API)の世界市場2017-2021

◆タイトル:Global Active Pharmaceutical Ingredients Market 2017-2021
◆商品コード:IRTNTR11059
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2016年12月8日
◆ページ数:60
◆資料形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD4,500 ⇒換算¥508,500見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD5,000 ⇒換算¥565,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、医薬品有効成分(API)の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、医薬品有効成分(API)の世界市場規模及び予測、種類別分析、製品別分析、主要国別分析、市場の成長要因、市場の課題、市場動向、競争状況などの情報をお届けいたします。

・エグゼクティブサマリー
・医薬品有効成分(API)の世界市場:市場概観
・医薬品有効成分(API)の世界市場:業界の構造分析
・医薬品有効成分(API)の世界市場:市場規模及び予測
・医薬品有効成分(API)の世界市場:種類別分析
・医薬品有効成分(API)の世界市場:製品別分析
・医薬品有効成分(API)の世界市場:アジア市場規模
・医薬品有効成分(API)の世界市場:アメリカ市場規模
・医薬品有効成分(API)の世界市場:ヨーロッパ市場規模
・医薬品有効成分(API)の世界市場:主要国別分析
・医薬品有効成分(API)の世界市場:成長要因
・医薬品有効成分(API)の世界市場:課題
・医薬品有効成分(API)の世界市場:市場動向
・医薬品有効成分(API)の世界市場:競争状況
...

※上記の和訳は最新内容ではない場合があります。下記の英文概要・目次が最新版です。

About Active Pharmaceutical IngredientsA drug is generally composed of APIs and excipients. Active Pharmaceutical Ingredients are chemical compounds or a combination of compounds that are used primarily to have the desired effect on biological systems. Excipients are inactive ingredients in a drug that are used to disperse APIs. APIs may be synthesized either through chemical or biotechnological methods.

Technavio’s analysts forecast the global active pharmaceutical ingredients market to grow at a CAGR of 6.61% during the period 2017-2021.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global active pharmaceutical ingredients market for 2017-2021. To calculate the market size, the report considers the sales of APIs in key applications areas of the pharmaceutical industry. The report considers the revenue generated from the sales of cardiovascular drugs, diabetes drugs, central nervous system (CNS) drugs, oncology drugs, and others.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Active Pharmaceutical Ingredients Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• Aurobindo Pharma
• Cipla
• Dr. Reddy’s Laboratories
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries

[Other prominent vendors]
• Abbott Laboratories
• Albemarle
• Amgen
• BASF
• Biocon
• Boehringer Ingelheim
• Bristol-Myers Squibb
• CIRON Drugs & Pharmaceuticals
• Dishman Pharmaceuticals and Chemicals
• Emcure Pharmaceuticals
• Ipca Laboratories
• Johnson Matthey
• Guilin Pharmaceutical
• Johnson & Johnson
• Lonza Group
• Merck
• Novartis
• Pfizer
• Roche

[Market driver]
• Strong focus on HPAPI
• For a full, detailed list, view our report

[Market challenge]
• Government regulations
• For a full, detailed list, view our report

[Market trend]
• Growing influence of key markets
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report
• Market overview

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Overview

PART 05: Market landscape
• Global APIs market
• Five forces analysis

PART 06: Market segmentation by production process
• Global APIs market by production process
• Global synthetic APIs market
• Global biotech APIs market

PART 07: Market segmentation by type
• Global APIs market by type

PART 08: Market segmentation by vendor type
• Global APIs market by vendor type
• Global captive APIs market
• Global merchant APIs market

PART 09: Geographic segmentation
• Global APIs market by geography
• APIs market in Americas
• APIs market in APAC
• APIs market in EMEA
• Global APIs market by therapeutic areas

PART 10: Market drivers
• Increasing incidence of age-related diseases globally
• Strong focus on HPAPI
• Measures against counterfeit drugs

PART 11: Impact of drivers

PART 12: Market challenges
• Government regulations
• Fierce competition among API manufacturers
• Less R&D spending
• Availability of counterfeit products

PART 13: Impact of drivers and challenges

PART 14: Market trends
• Growing influence of key markets
• Emergence of Africa
• Increasing outsourcing activities

PART 15: Vendor landscape
• Competitive scenario
• Aurobindo Pharma
• Cipla
• Dr. Reddy’s Laboratories
• Sun Pharmaceutical Industries Limited
• Teva Pharmaceutical Industries
• Other prominent vendors

PART 16: Appendix
• List of abbreviations

PART 17: Explore Technavio

[List of Exhibits]

Exhibit 01: Global APIs market
Exhibit 02: Market segmentation by production process
Exhibit 03: Market segmentation by type
Exhibit 04: Market segmentation by vendors
Exhibit 05: Market segmentation by geography
Exhibit 06: Global APIs market 2016-2021 ($ billions)
Exhibit 07: Forecast of global APIs market 2016-2021
Exhibit 08: Five forces analysis
Exhibit 09: Global APIs market by production process 2016 and 2021
Exhibit 10: Global synthetic APIs market 2016-2021
Exhibit 11: Forecast for synthetic APIs market 2016-2021
Exhibit 12: Global biotech APIs market 2016-2021 ($ billions)
Exhibit 13: Forecast of biotech APIs market 2016-2021
Exhibit 14: Global biotech APIs market by product type 2016
Exhibit 15: Global APIs market by type 2016 and 2021
Exhibit 16: Global conventional APIs market 2016-2021 ($ billions)
Exhibit 17: Forecast of conventional APIs market 2016-2021
Exhibit 18: Global HPAPIs market 2016-2021 ($ billions)
Exhibit 19: Forecast of HPAPIs market 2016-2021
Exhibit 20: Global HPAPIs market by production process 2016
Exhibit 21: Global HPAPIs market by type 2016
Exhibit 22: Global APIs market by vendor type 2016 and 2021
Exhibit 23: Global captive APIs market 2016-2021 ($ billions)
Exhibit 24: Forecast of captive APIs market 2016-2021
Exhibit 25: Global merchant APIs market 2016-2021 ($ billions)
Exhibit 26: Forecast of merchant APIs market 2016-2021
Exhibit 27: Global merchant APIs market by type 2016
Exhibit 28: Global APIs market by geography 2016 and 2021
Exhibit 29: APIs market in Americas 2016-2021 ($ billions)
Exhibit 30: Forecast of APIs market in Americas 2016-2021
Exhibit 31: Key leading countries in APIs market in Americas 2016
Exhibit 32: APIs market in APAC 2016-2021 ($ billions)
Exhibit 33: Forecast of APIs market in APAC 2016-2021
Exhibit 34: Key leading countries in APIs market in APAC 2016
Exhibit 35: APIs market in EMEA 2016-2021 ($ billions)
Exhibit 36: Forecast of APIs market in EMEA 2016-2021
Exhibit 37: Key leading countries in APIs market in EMEA 2016
Exhibit 38: Global APIs market by therapeutic areas 2016
Exhibit 39: Impact of drivers
Exhibit 40: R&D spending % change 2013-2022
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Key vendors of global APIs market
Exhibit 43: Aurobindo Pharma: Business segmentation
Exhibit 44: Cipla: Business segmentation
Exhibit 45: Dr. Reddy’s Laboratories: Business segmentation by revenue 2015
Exhibit 46: Sun Pharmaceutical Industries Limited: Business segmentation by revenue 2015
Exhibit 47: Teva Pharmaceutical Industries: Business segmentation



【掲載企業】

Aurobindo Pharma, Cipla, Dr. Reddy's Laboratories, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries, Abbott Laboratories, Albemarle, Amgen, BASF, Biocon, Boehringer Ingelheim, Bristol-Myers Squibb, CIRON Drugs & Pharmaceuticals, Dishman Pharmaceuticals and Chemicals, Emcure Pharmaceuticals, Ipca Laboratories, Johnson Matthey, Guilin Pharmaceutical, Johnson & Johnson, Lonza Group, Merck, Novartis, Pfizer, Roche.

【資料のキーワード】

医薬品有効成分(API)、原薬、製薬、APIメーカー

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

【免責事項】
※当資料上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当資料に記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当資料上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[医薬品有効成分(API)の世界市場2017-2021]についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆